Reactivity to human papillomavirus type 16 Ll virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1095-1100

  Van Doornum, G J J ^a,b,d   Korse, C M ^b   Buning Kager, J C G M ^b   Bonfrer, J M G ^b   Horenblas, S ^b   Taal, B G ^b   Dillner, J ^c,e  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical cancer; HPV 16 serology; Oesophageal carcinoma; Oropharyngeal carcinoma; Penile carcinoma; Vaginal and vulvar cancer

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENITAL TRACT CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PENIS CARCINOMA; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; STOMACH CANCER; UTERINE CERVIX CARCINOMA; VAGINA CARCINOMA; VIRUS CAPSID; VIRUS PARTICLE; WART VIRUS;

AGED; ANTIBODIES, VIRAL; CAPSID PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; SEROEPIDEMIOLOGIC STUDIES; TONGUE NEOPLASMS; VIRAL PROTEINS; VIRION;

EID: 0038030711     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600870     Document Type: Article

References (56)

1. Benamouzig R, Jullina E, Chang F, Robaskiewicz M, Flejou JF, Raoul JL, Coste T, Couturier D, Pompidou A, Rautureau J (1995) Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroenterology 109: 1876-1881
2. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S (1997a) Prospective seroepidemiological study of role of human papilloma virus in non-cervical anogenital cancers. BMJ 315: 646-649
3. Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J (1997b) A prospective, seroepidemiologic study on the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 57: 3989-3992
4. Bontkes HJ, De Gruijl TD, Walboomers JMM, Schiller JT, Dillner J, Helmerhorst TJM, Verheyen RHM, Scheper RJ, Meijer CJLM (1999) Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol 80: 409-417
5. Campo MS (1992) Cell transformation by animal papillomaviruses. J Gen Virol 73: 217-222
6. Carter JJ, Madelein MM, Shera K, Schwarz SM, Cushing-Haugen KL, Wipf GC, Porter P, Daling JR, McDougal JK, Galloway DA (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61: 1934-1940
7. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamini H (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84: 263-270
8. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG (1994) Epi Info, Version 6: A Word Processing, Databases, and Statistics Program for Epidemiology on Microcomputers. Atlanta, GA, USA: Centers for Disease Control and Prevention
9. De villiers EM (1992) Laboratory techniques in the investigation of human papillomavirus infection. Genitourinary Med 68: 50-54
10. De Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R, Syrjanen S (1999) An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 81: 225-228
11. Dianzani C, Bucci M, Pierangeli A, Calvieri S, Degener AM (1998) Association of human papillomavirus type 11 with carcinoma of the penis. Urology 51: 1046-1048
12. Dillner J (1990) Mapping of linear epitopes of the human papillomavirus type 16. The E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer 46: 703-711
13. Dillner J (1995) Serology of human papillomavirus. Cancer J 8: 264-269
14. Dillner J, Knekt P, Schiller JT, Hakulinen T (1995) Prospective seroepidemiological evidence that human papilloma-virus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Br Med J 311: 1346
15. Dillner J, Von Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol 205(Suppl): 189-193
16. Forastiere A, Koch W, Trotti A, Sidranski D (2001) Head and neck cancer. N Engl J Med 345: 1890-1900
17. Franceschi S, Muñoz N, Snijders PJF (2000) How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 356: 871-872
18. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720
19. Griffiths TR, Mellon JK (1999) Human papillomavirus and urological tumours: I. Basic science and role in penile cancer. Br J Urol Int 84: 579-586
20. Grussendorf-Cronen EI (1997) Anogenital premalignant and malignant tumors (including Buschke-Lowenstein tumors). Clin Dermatol 15: 377-388
21. Heim K, Widschwendter A, Pirschner G, Wieland U, Awerkiew S, Christensen ND, Bergant A, Marth C, Höpfl R (2002) Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer. Am J Obstetr Gynecol 186: 705-711
22. WHO (1979) International Classification of Disease. 9th rev. Geneva: World Health Organization
23. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT (1994) A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86: 494-498
24. Kok TC, Nooter K, Tjong-A-Hung SP, Smits HL, ter Schegget J (1997) No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Eur J Cancer 33: 1865-1868
25. Lagergren J, Wang Z, Bergström R, Dillner J, Nyren O (1999) Human papillomavirus infection and esophageal cancer: a nation-wide seroepidemiologic case-control study. J Natl Cancer Inst 91: 156-162
26. Lambot MA, Haot J, Peny MO, Fayt I, Noel JC (2000) Evaluation of the role of human papillomvirus in oesophageal squamous cell carcinoma in Belgium. Acta Gastroenterol Belg 63: 154-156
27. Lavergne D, De Villiers EM (1999) Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 80: 681-684
28. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aomaa A, Kirnbauer R, Koskela P, Paavonen P, Peto R, Schiller JT, Hakama M (1996) Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 312: 537-539
29. Levi JE, Rahal P, Sarkis AS, Villa L (1998) Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 76: 779-783
30. Lindel KK, Beer KT, Laisssue J, Greiner RH, Aebersold DM (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx. Cancer 92: 805-813
31. Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CMC, Williamson AL (2000) Seroreactivity to human papillomavirus types 16, 18, 31, 33, and 45 virus-like in South African women with cervical cancer and cervical intraepithelial neoplasia. J Med Virol, 60: 403-410
32. Miller BA, Davidson M, Myerso D, Icenogle J, Lanier AP, Tan J, Beckmann AM (1997) Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives. Int J Cancer 71: 218-222
33. Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125-1131
34. Muñoz N, Bosch FX (1989) Epidemiology of cervical cancer. In Human Papillomavirus and Cervical Cancer, Muñoz N, Bosch FX, Jensen OM (eds). pp 9-39. Lyon: International Agency for Research on Cancer
35. Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Muñoz N, Bosch FX, De Sanjosé S, Viscidi R, Lowy DR, Schiller JT (1995) Serologic responses to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Columbia and Spain. J Infect Dis 172: 19-24
36. Nonnenmacher B, Kruger Kjaer S, Svare EI, Scott JD, Hubbert N, Van den Brule AJC, Kirnbauer R, Walboomers JMM, Lowy R, Schiller JT (1996) Seroreactivity to HPV 16 virus-like particles as a marker for cervical cancer risk in high-risk populations. Int J Cancer 68: 704-709
37. Picconi M, Eiján AM, Distéfano AL, Puyeo S, Alonio LV, Gorostidi S, Teyssié AR, Casabé A (2000) Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol 61: 65-69
38. Poblet E, Alfar L, Fernander-Segoviano P, Jimenez-Reyes J, Salido EC (1999) Human papillomavirus-associated penile squamous cell carcinoma in HIV-positive patients. Am J Surg Pathol 23: 1119-1123
39. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcionogenesis. Am J Pathol 159: 1211-1218
40. Saegusa M, Hashimura M, Takaano Y, Ohbu M, Okayasu L (1997) Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. Mol Pathol 50: 101-104
41. Sillins I, Avall-Lundqvist E, Tadesse A, Jansen KU, Stendahl U, Lenner P, Zumbach K, Pawlita M, Dillner J, Frankendal B (2002) Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynaecol Oncol 85: 333-338
42. Smits HL, Tjong-A-Hung SP, Ter Schegget J, Nooter K, Kok T (1995) Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 46: 213-215
43. Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, Wacholder S, Clayman B, Viscidi RP (1998) A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 7: 305-313
44. Sur M, Cooper K (1998) The role of human papilloma virus in esophageal cancer. Pathology 30: 348-354
45. Tornesello ML, Buonaguro FM, Meglio A, Buonaguro L, Beth-Giraldo E, Giraldo G (1997) Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78: 2199-2208
46. Van Doornum G, Prins M, Andersson-Ellström A, Dillner J (1998) Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 after newly acquired infection. Sexually Transmitted Infect 74: 354-360
47. Van Doornum GJJ, Prins M, Pronk L, Coutinho RA, Dillner J (1994) A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA. J Clin Diagn Lab Immunol 1: 633-639
48. Wideroff L, Schiffman M, Haderer P, Armstrong A, Greet CE, Manos MM, Burk RD, Scott DR, Sherman ME, Schiller JT, Hoover RN, Tarone RE, Kirnbauer R (1999) Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case - control study of cervical squamous intraepithelial lesions. J Infect Dis 180: 1424-1428
49. Wideroff L, Schiffman M, Hubbert N, Kirnbauer R, Schiller J, Greer C, Manos MM, Dawsey SM, Li Jun-Yao, Brinton L (1996b) Serum antibodies to HPV 16 virus-like particles are not associated with penile cancer in Chinese males. Viral Immunol 9: 23-25
50. Wideroff L, Schiffmann MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Buckland J, Lowy D, Schiller JT (1996a) Epidemiological determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and - negative women. J Infect Dis 174: 937-943
51. Wideroff L, Schiffman MH, Nonnemacher B, Hubert N, Kirnbauer R, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Kurman RJ, Buckland J, Tarone RE, Schiller J (1995) Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case - control study of cervical neoplasia. J Infect Dis 172: 1425-1430
52. Wikström A, Popescu C, Forslund O (2000) Asymptomatic penile HPV infection: a prospective study. Int J STD & AIDS 11: 80-84
53. Wikström A, Van Doornum GJJ, Kirnbauer R, Quint WGV, Dillner J (1995a) Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condylomata acuminata or new asymptomatic infection. J Med Virol 46: 368-374
54. Wikström A, Van Doornum GJJ, Schiller JT, Dillner J (1995b) Identification of HPV seroconversions. J Gen Virol 76: 529-539
55. Zumbach K, Kisseljov F, Sacharova S, Shaichaev G, Semjonova L, Pavlova L, Pawlita M (2002) Antibodies against oncoproteins E6 an E7 of human papillomavirus types 16 and 18 in cervical carcinoma patients from Russia. Int J Cancer 85: 313-318
56. Zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186: 131-156